Pfizer knew even before its blockbuster cholesterol-lowering statin drug Lipitor hit the market that it could cause increases in blood sugar levels in women and put them at risk for type 2 diabetes. However, the drug company refused to warn doctors or patients until 2011, when the Food and Drug Administration (FDA) ordered them to do so.
The government-ordered warning was based on an investigation prompted by the results of the JUNIPER trial, which reported a 27 percent increase in diabetes with patients taking statin medication. In that study, men had a 16 percent increase in diabetes, but women showed a shocking 50 percent increase.
Type 2 diabetes is a serious health problem. Those who develop the chronic disease must follow a strict diet for the rest of their lives, check their blood sugar levels regularly, and often take medication. Uncontrolled diabetes can lead to heart disease, kidney disease, amputations due to neuropathy, dementia and blindness.
Even more concerning is that women who develop diabetes have a higher incidence of the adverse events caused by the disease, such as coronary heart disease, peripheral artery disease, and heart failure.
Thousands of lawsuits have been filed against Pfizer claiming the company failed to warn the public of the diabetes risk with Lipitor while making billions of dollars in sales of the drug. Attorneys with Beasley Allen Law Firm are currently investigating cases of diabetes in patients who developed the disease after using Lipitor.
If you are a woman between the ages of 51 and 70 years of age with a BMI of 30 or less at the time of diabetes diagnosis, have no family history of diabetes or previous heart attacks, and developed diabetes after taking Lipitor consistently for at least two months or were diagnosed with the disease within six months after stopping the medication, you may be entitled to compensation.
Source: Righting Injustice